STACY ROYALL: Open Payments
NPI 1417500307 · RADFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,361 in 64 payments from 8 companies in 2025. Trend: 2023 $456 · 2024 $759 · 2025 $1,361
Food & beverage: $1,249Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $480 |
| Janssen Pharmaceuticals, Inc | 6 | $264 |
| E.R. Squibb & Sons, L.L.C. | 9 | $150 |
| Neurocrine BioSciences, Inc. | 7 | $148 |
| Alkermes, Inc. | 12 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $137 |
| Lundbeck LLC | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: INVEGA SUSTENNA, AUSTEDO XR, UZEDY, COBENFY, INGREZZA, CAPLYTA, ARISTADA, ABILIFY MAINTENA.
Industry payments across VA — which companies pay providers there.
